Axq Capital »

Monte Rosa Therapeutics shares owned by Axq Capital

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Axq Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $216k 14k 15.68

More positions owned by Axq Capital

Bellring Brands Common Stock (BRBR)
Rocket Cos Com Cl A (RKT)
O'reilly Automotive (ORLY)
UnitedHealth (UNH)
Microsoft Corporation (MSFT)
Xylem (XYL)
Sofi Technologies (SOFI)
Duolingo Cl A Com (DUOL)
Marsh & McLennan Companies
Honeywell International (HON)
Blackrock (BLK)
Stryker Corporation (SYK)
NVIDIA Corporation (NVDA)
Interactive Brokers Group In Com Cl A (IBKR)
Lennar Corp Cl A (LEN)

View all positions for Axq Capital

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics